Why Moderna Shares Are Surging Today

Loading...
Loading...

Moderna Inc MRNA shares are trading higher by 6.2% at $348.47, rebounding after the stock dipped on Tuesday amid vaccine supply concerns. Vaccine stocks have also gained recently amid COVID-19 Delta variant concerns.

Moderna shares have broken out over the past month, trading higher by 54.4%. Moderna shares are also trading higher over the past 5 sessions by 8.1%.

Moderna is commercial-stage biotech that was founded in 2010. The firm's mRNA technology was rapidly validated with its COVID-19 vaccine, which was authorized in the United States in December 2020.

Moderna had 24 mRNA development programs as of early 2021, with 13 of these in clinical trials. Programs span a wide range of therapeutic areas, including infectious disease, oncology, cardiovascular disease and rare genetic diseases.

Moderna has a 52-week high of $362.00 and a 52-week low of $54.21.

Posted In: Moverswhy it's moving
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!

Loading...